Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Assets (2016 - 2025)

Historic Return on Assets for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Q3 2025 value amounting to 0.35%.

  • Ironwood Pharmaceuticals' Return on Assets rose 9400.0% to 0.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.35%, marking a year-over-year increase of 9400.0%. This contributed to the annual value of 0.25% for FY2024, which is 18500.0% up from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Return on Assets stood at 0.35% for Q3 2025, which was up 9400.0% from 0.28% recorded in Q2 2025.
  • Ironwood Pharmaceuticals' Return on Assets' 5-year high stood at 0.59% during Q2 2021, with a 5-year trough of 2.88% in Q1 2024.
  • For the 5-year period, Ironwood Pharmaceuticals' Return on Assets averaged around 0.28%, with its median value being 0.17% (2022).
  • As far as peak fluctuations go, Ironwood Pharmaceuticals' Return on Assets plummeted by -30400bps in 2024, and later skyrocketed by 30800bps in 2025.
  • Ironwood Pharmaceuticals' Return on Assets (Quarter) stood at 0.48% in 2021, then crashed by -66bps to 0.16% in 2022, then crashed by -1647bps to 2.53% in 2023, then surged by 111bps to 0.28% in 2024, then grew by 27bps to 0.35% in 2025.
  • Its Return on Assets stands at 0.35% for Q3 2025, versus 0.28% for Q2 2025 and 0.21% for Q1 2025.